Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...

Medical Information in the Digital Age – Quick and Efficient Meets Responsive and Responsible

Medical Information (MI teams across the pharmaceutical industry respond to product-related medical queries from HCPs...
finding the easiest way through a maze

Plain Language in Plain Sight: Why Making It Easier for Patients to Access Content They Understand Pays Off

With so many different types of Plain Language Summaries, and the interchangeable terms used for...
Digital Medical Communications Teams in Pharma

The Evolution of Medical Communications: How to Get the Most Out of Standard Response Documents

Better patient awareness has led to a rapid increase in the number of MI requests...
Racial and Ethnic Diversity in Pharma and Clinical Trials

Racial and Ethnic Diversity in Pharma and Clinical Trials

CACTUS strongly supports inclusion and diversity and is working hard to raise awareness about this...
DE&I Infographic #1

The Business Case for Diversity, Equity, and Inclusion (DE&I) in the Pharma Industry

To learn how much businesses can gain from more diverse and inclusive workplaces and why...
diversity and inclusion

Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy

Read this update on how the New England Journal of Medicine is trying to promote...

Learn more ABOUT our company.